Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition

“We have been taking new policy steps at the FDA to support downward pressure on drug prices by helping to clear a path for more efficient generic development,” says FDA Commissioner Scott Gottlieb, M.D.

Read More »

Empowered Patients Require Authentic Engagement Strategies

Patients are becoming increasingly knowledgeable about their personal health and about the healthcare options available to them – and that is a good thing.

Read More »

What’s Next: An Innovation Series Powered by Ogilvy Consulting

This webinar, moderated by Ogilvy Consulting’s Ritesh Patel and led by Ogilvy Health’s Angelo Campano and Chris Andrews, will focus on the use of data in healthcare marketing. The webinar will take a closer look at Ogilvy Consulting’s Tripl offering, a proprietary platform that connects data, people and technology, illustrated with real market examples.

Read More »

Agenda 2019: On pricing transparency

For years and years, pharmaceutical pricing has been under attack by consumers, professionals, and payers. More recently, the U.S. government has dramatically stepped up its assault, with price reduction proposals from Congress and stern words from President Trump indicating that drug pricing is a major ongoing focus of the administration. The 2018 timeline was dotted with government jabs at pharma pricing, as well as some attempts to take real action.

Read More »

Agenda 2019: Pharma is ready for personalized analytics

A sales rep preparing for her week isn’t thinking, What’s in my sales dashboard? What is my progress towards my call plan? She’s thinking, What are the burning issues in my territory this week? How should I adjust my plan based on the latest events and information that I have? Then she manually navigates her way through dashboards and reports to find these answers.

Read More »

Agenda 2019: Voice assistants

The market research company Gartner predicts that consumer demand for voice devices such as Amazon Echo and Google Home will generate $3.5 billion by 2021. These intelligent voice assistants, plus other digital technologies such as the Apple Watch, are slowly but steadily being adopted in healthcare.

Read More »

Agenda 2019: What’s on the radar for 2019?

Ogilvy Health recently asked some of its agency leaders – in creative, payer, digital, planning, and account – to share what they’re tracking in 2019.

Read More »

Agenda 2019: Personalizing engagement with accurate customer data

In the era of precision medicine, life sciences companies are transforming customer engagement with complete, accurate and up-to-date customer data.

Read More »

Agenda 2019: Agency relationships, by the numbers

Most pharmaceutical brands are really happy with a handful of their agencies, satisfied with some, and not too thrilled with one or two. TGaS uncovered four areas to watch in 2019 through its benchmark-based consultancy.

Read More »

Value of Medicines Special Feature – Medicare for All: What Is It?

With reports that the House Democratic leadership has agreed to hearings on Medicare for All, and a Harvard/Politico survey demonstrating that 84 percent of Democrats support a tax-funded national healthcare plan, the concept of Medicare for All is moving into the healthcare debate. At this point, however, Medicare for All is a concept defined by only general terms.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!


Ad Right Bottom